Study of Phenoptin in Subjects With Phenylketonuria Who Participated in Protocols PKU-004 or PKU-006
Status:
Completed
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the safety of long-term treatment with Phenoptin
in subjects with phenylketonuria (PKU) who participated in Phase 3 clinical studies with
Phenoptin.